SciELO - Scientific Electronic Library Online

 
vol.141 issue4Sites of prolactin inhibition on gonadotropin-induced estrogen production in cultured rat granulosa cellsBases to determine the dose of vitamin C in pregnancy author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Gaceta médica de México

On-line version ISSN 2696-1288Print version ISSN 0016-3813

Abstract

SANCHEZ-MENDIOLA, Melchor; MARTINEZ-NATERA, Octavio C.; HERRERA-MALDONADO, Nazarea  and  ORTEGA-ARROYO, Jesús. Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfanctant. A controlled study. Gac. Méd. Méx [online]. 2005, vol.141, n.4, pp.267-271. ISSN 2696-1288.

Background: Hyaline membrane disease (HMD) due to lung surfactant deficiency in the preterm newborn is an important cause of neonatal morbidity and mortality. Exogenous lung surfactant has transformed HMD therapy in developed countries, but an equivalent benefit has not been accomplished in developing countries due to a variety of factors. Porcine surfactant developed in Cuba is an inexpensive alternative to other surfactants, and its use has not been studied in our settings. Methods: A randomized, open, prospective and controlled trial was undertaken in 44 preterm newborns with HMD diagnosis. One group received bovine surfactant (BS) (Survanta) and the other Cuban porcine surfactant (PS) (Surfacen). The following clinical response variables were evaluated: oxygenation and ventilation indexes, days with supple mentary oxygen, days with mechanical ventilation, incidence of compli cations, time of hospitalization, and mortality. Results: 23 Patients received bovine surfactant and 21 the porcine type. The two groups were clinically similar, with patterns of oxygenation and ventilation response that were the same between groups, with a tendency to higher initial oxygenation increase in the PS group. The incidence of complications was similar between groups. Ten Patients (47.6%) died in the PS group, versus 12 (52.2%) in the BS group (p>0.05) Conclusions: Porcine surfactant had similar clinical effects than bovine surfactant in the oxygenation and ventilation variables, with no significant differences in complications or mortality. Porcine surfactant is an effective and lower cost alternative to bovine surfactant in the treatment of HMD.

Keywords : Pulmonary surfactants; hyaline membrane disease; newborn respiratory distress syndrome; premature infant.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License